Evidence map›Paper›PMID 40582729›Full record

ReviewCardiology clinics2025

Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations.

Melinda Solomon, Sophie Claudel, Ashish Verma

Abstract readReview
In one paragraph

Review in Cardiology clinics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Melinda SolomonSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, 650 Albany Street, X504, Boston, MA 02118, USA.
Sophie ClaudelSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, 650 Albany Street, X504, Boston, MA 02118, USA.
Ashish VermaSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, 650 Albany Street, X504, Boston, MA 02118, USA. Electronic address: ashverma@bu.edu.

Funding

Multidisciplinary Training Program in Cardiovascular EpidemiologyT32HL125232 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Matthew G. Nayor, Vanessa Xanthakis · 2016 to 2026
$5.0M
NHLBI NIH HHS T32 HL125232
6 · The paper itself

Abstract

Research has revealed that hypertension, chronic kidney disease, and type 2 diabetes mellitus have a common underlying pathophysiology of excess/or dysfunctional adiposity and share similar treatment plans. As a result, the American Heart Association issued a Presidential Advisory on Cardiovascular-Kidney-Metabolic (CKM) Health. The advisory outlines the definition and stages in the progression of CKM syndrome, with cardiovascular disease as the final outcome. It also emphasizes the importance of evaluating metabolic and social risk factors and considering various therapeutic approaches, including the involvement of a multidisciplinary team.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Metabolic SyndromeRenal Insufficiency, ChronicHumansRisk AssessmentRisk FactorsCardiovascular diseaseChronic kidney diseaseMetabolic disease

Identifiers

PMID40582729
PMCPMC13077884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.